Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer

Keyvan Koushan, MD, FRCSC

Audio
Published 2018

clinical trials, dry AMD (non-neovascular), age-related macular degeneration, lasers, retinal pigment epithelium, geographic atrophy, drusen, clinical trials, delivery devices

Common Age-Related Macular Degeneration Genetic Risk Variants and Geographic Atrophy Lesion Growth in the Chroma and Spectri Phase 3 Lampalizumab Trials
Karl G. Csaky, MD, PhD
Annual Meeting Talks
2018
A Descriptive Analysis of Patients Who Received Pegcetacoplan and Anti-VEGF for the Treatment ofGeographic Atrophy and Neovascular AMD
Nimesh A. Patel, MD
Annual Meeting Talks
2025
Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022

Category: AMD-Non-Neovascular

Retinal Pigment Epithelium
Geographic Atrophy
age-related macular degeneration (AMD)
The Retina Channel
drug delivery devices
clinical trials
Lasers
Dry AMD

See more

Member Podcasts
Keyvan Koushan, MD, FRCSC

Sign in to view content

Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer

Related

See more